Stayble Therapeutics presents at Stora Aktiedagen in Gothenburg
Andreas Gerward, CEO of Stayble Therapeutics AB, will attend Stora Aktiedagen in Gothenburg on 8 November 2022. Topics to be discussed include Stayble's market potential, the ongoing Phase IIb study and the way forward with ongoing partner discussions and the regulatory preparations for the Phase III study.On Tuesday 8, Stayble Therapeutics will participate in Aktiespararnas event from 11.00-11.30. Andreas Gerward will present the company and answer questions. Watch the presentation live on the web, via www.aktiespararna.se/tv/live. The event is open to everyone and does not require